Key Takeaways:
- TD Cowen cut its price target on Strategy, citing sustained Bitcoin weakness
- Strategy shares fell more than 28% last week as BTC dropped below $60,000
- The stock broke a nine-day losing streak Monday before resuming declines Tuesday
Key Takeaways:

Strategy shares fell Tuesday after TD Cowen slashed its price target on the Bitcoin proxy, as the cryptocurrency traded below $60,000.
TD Cowen lowered its valuation on the Tysons Corner, Virginia-based company, citing sustained weakness in Bitcoin's price as a risk to Strategy's balance sheet and its ability to deploy capital for additional purchases, according to a research note. The investment bank's revision adds to mounting pressure on the company, which has relied on debt and equity issuance to fund its Bitcoin acquisition strategy.
Strategy tumbled more than 28% in the week through Monday, according to Investing.com data, as Bitcoin slid below $60,000. The stock had broken a nine-day losing streak on June 29, its longest run of consecutive declines, before giving back gains Tuesday. The decline highlighted the company's leveraged exposure to the cryptocurrency and renewed concerns about its balance sheet at depressed coin prices, with investors questioning how the company would manage its debt obligations if Bitcoin prices remain low.
The price target revision highlights the risks embedded in Strategy's model of funding Bitcoin purchases through debt and equity issuance. With Bitcoin trading below $60,000, questions are mounting over the company's ability to service its obligations tied to its digital asset holdings. The weakness in Strategy also weighed on other crypto-exposed equities, as investors reassessed the correlation between digital asset prices and the balance sheets of companies that hold them. The broader sell-off in risk assets has been compounded by a rotation out of technology and into defensive names, with pharmaceutical stocks such as Johnson & Johnson, Merck and Eli Lilly among the beneficiaries, according to Investing.com. For a company whose stock performance has been tightly linked to Bitcoin's price trajectory, the sustained weakness creates a feedback loop that could accelerate selling pressure.
For Strategy, the path forward depends on a recovery in Bitcoin prices. The company's model of accumulating Bitcoin through capital markets has been a key driver of its stock performance, but the recent slide has exposed the downside risk of that approach. If Bitcoin fails to reclaim the $60,000 level, further analyst downgrades and selling pressure on Strategy shares could follow. The TD Cowen revision marks the latest in a series of analyst adjustments on the stock, reflecting growing caution on the sustainability of the Bitcoin-driven investment thesis as the cryptocurrency extends its decline.
The sell-off in Strategy comes as the broader cryptocurrency market faces headwinds from macroeconomic uncertainty and reduced risk appetite among institutional investors. Bitcoin's decline below $60,000 has put pressure on companies with significant exposure to digital assets. For Strategy, which has positioned itself as the largest corporate holder of Bitcoin, the current environment represents a stress test of its capital allocation strategy, with the outcome likely to influence how other companies approach corporate Bitcoin treasury strategies.
This article is for informational purposes only and does not constitute investment advice.